Gastric cancer (GC) is among the most frequent malignancies, and increasing evidence supports the contribution of microRNA (miRNAs) to cancer progression. The signaling pathways and epithelialCmesenchymal transition (EMT)-related proteins were detected with western blot. The results showed that miR-1254 inhibited the proliferation, migration and invasion in vitro and suppressed tumorigenesis in vivo. Smurf1 was shown to be the direct target of miR-1254. Overexpressing Smurf1 could partially counteract the effects caused by miR-1254. Similarly, the effects of the miR-1254-inhibitor were also rescued by Smurf1-shRNA. Furthermore, we found that miR-1254 inhibited EMT and decreased the PI3K/AKT signaling pathway through downregulating Smurf1. In summary, overexpression of miR-1254 could suppress proliferation, migration, invasion, and EMT via PI3K/AKT signaling pathways by downregulation of Smurf1 in GC, which suggests CD4 a potential therapeutic target for GC. Introduction Gastric cancer (GC) is one of the most frequent malignancies, particularly in Eastern Asia, its mortality and occurrence rank the 4th and the 3rd, respectively, in the globe1. In 2015, approximated 679,100 fresh GC instances and 498,000 fatalities happened in China2. Despite medical result of GC continues to be improved by early analysis steadily, AZD8055 kinase inhibitor surgical methods and postoperative chemotherapy, the 5-yr survival price of advanced GC individuals is low3. Consequently, it is vital to elucidate the molecular systems underlying the development and advancement of GC. MicroRNAs (miRNAs) certainly are AZD8055 kinase inhibitor a course of evolutionary conserved, little noncoding RNAs comprising 18C25 nucleotides, which downregulate focus on mRNAs manifestation by binding towards the 3-untranslated regions (3-UTR), leading to suppression of translation or mRNAs degradation4,5. The first miRNA was discovered as a AZD8055 kinase inhibitor small RNA transcribed from the lin-4 locus in 19936, and mammalian miRNA (let-7) was identified for the first time in 20007. So far, miRNAs have been described as playing an AZD8055 kinase inhibitor important role in the progression of cancer, such as tumor proliferation, invasion, and metastasis8. Dysregulation of miRNAs expression promotes the development of cancer due to the activation of oncogenes and silence of tumor-suppressor genes9,10. Accumulating evidence has revealed that miR-1254 might strongly correlate to human cancer, such as non-small-cell lung carcinoma, thyroid cancer, and colorectal cancer11C13. However, the biological functions and molecular mechanisms of miR-1254 in GC have not been reported. In this study, we found that miR-1254 inhibited the progression of GC both in vitro and in vivo. Smad ubiquitin regulatory factor 1 (Smurf1), a C2-WW-HECT ubiquitin ligase, is involved in a variety of biological processes, such as bone homeostasis, embryogenesis, and viral autophagy14C16. Moreover, an increasing body of evidence has revealed that Smurf1 exerts a promoting effect in carcinogenesis by regulating downstream proteins17,18. Previous studies revealed that Smurf1 as a cancer-related gene could promote EMT and positively regulate the PI3K/AKT signaling pathway, which influenced cancer cell proliferation, migration, and invasion19. Bioinformatics analysis and relevant functional assay were used to confirm that Smurf1 was a putative direct target of miR-1254 and played a crucial role in human GC. In this study, we aimed to investigate the role of miR-1254 in GC and the relation to Smurf1. Our results indicated that overexpressed miR-1254 could inhibit the development and progression of GC by targeting Smurf1 through PI3K/AKT signaling pathways in vitro and in vivo. These findings also provided a basis for miR-1254 as a potential therapeutic target for GC. Results MiR-1254 is down-regulated in human GC tissues and cell lines To confirm whether miR-1254 was abnormally regulated in GC tissues, 90 pairs of GC tissues and adjacent normal tissues were collected to examine the relative expression of miR-1254 by miRNA RT-PCR. As shown in Fig.?1a, compared with the paired adjacent tissues, the expression of miR-1254 was lower in human GC cells. The manifestation of miR-1254 was.